1. Home
  2. Clinical Topics
  3. FDA approves extended depth-of-focus IOL
Clinical TopicsDrugs and DevicesWeb Exclusives

FDA approves extended depth-of-focus IOL


On July 15, the Food and Drug Administration (FDA) approved Tecnis Symfony intraocular lens (IOL), the first IOL that provides cataract patients with an extended depth-of-focus, which helps improve their visual acuity at near, intermediate, and far distances. Read more

Leave a Reply

Your email address will not be published. Required fields are marked *

Fill out this field
Fill out this field
Please enter a valid email address.

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.


Recent Posts